Welcome to ABX-CRO

The independent full-service CRO for cutting-edge research in neuroscience, oncology and molecular imaging. With a unique translational medicine approach, we are happy to develop your product from bench to bedside.



QDOSE to be part of commercial partnership with Telix

We are proud to announce that the dosimetry software QDOSE® designed by us and our development partner Quantinm AB will now become part of a commercial partnership with Telix. Telix intends to integrate the platform into its therapeutic radiopharmaceutical programmes...

Visiting SNMMI 2024 in Toronto

Summer 2024 is coming up and as every year we are returning to the SNMMI 2024 in Toronto, Canada on June 8-11. Our two General Managers, Dr. Andreas Kluge and Andreas Fintelmann, and the CEO of ABX-CRO INC, Moritz Kallerhoff, will be there again accompanied by our...

Visiting Chile for TWC 2024

This year we will start our conference activities in Santiago, Chile for the 7th Theranostics World Congress. From March 22 to 24 you can find us at booth #A06 and talk with Dr. Andreas Kluge and Andreas Fintelmann, our General Managers, about how ABX-CRO can help you...

Phase 2 study for improvement of prostate cancer diagnosis

Prostate cancer awareness month may already be over, but men's health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...

TRP EU in December 2023

We are happy to announce that our last conference this year will be the Targeted Radiopharmaceuticals Summit Europe. Come and find us in Berlin from 5 to 7 December. Join us for our talks: “Using multiple legislations to optimise clinical trial conduct (EU & USA)”...

ABX-CRO announces the opening of ABX-CRO India at EANM’23

Indian scientists led the way to today´s nuclear medicine: Suresh Srivastava: Fundamental 99mTechnetium generator technology and labelling Nagichettiar Satyamurthy: 18F-labelling methodology & molecular pharmacology Shrikant Deshpande: DOTA as chelator for...


On to the next congress – from September 9-13 we will head to Vienna to be part of the 36th Annual Congress of the European Association of Nuclear Medicine – the EANM'23. The EANM industrial exhibition gives an extensive overview of the latest achievements in...

TRP US 2023 and AGRR

After returning from a successful SNMMI in Chicago, we are now excited to participate in the second Targeted Radipharmaceuticals Summit US - the TRP US. Moritz Kallerhoff, ABX-CRO INC.'s Chief Executive Officer, will be on site for us in Boston from July 25-27 to...

ABX-CRO goes SNMMI 2023

Once again we will be attending the premier event for education, science, research and networking in nuclear medicine and molecular imaging - SNMMI 2023 - you will find us in Chicago, Illinois, June 24-27, Booth #3082. We have been an almost annual attendee of this...

Andreas Fintelmann visiting iSRS23

Our General Manager Andreas Fintelmann is heading to Honolulu in May to attend the 25th iSRS conference. From 22-25.5. there will be an outstanding collection of plenaries and workshops. A great opportunity to reactivate old connections and make new ones while in the...
Brain Perfusion or CT scan of Blood flow in the brain 3d rendering image on the screen with CT Scan room.


With more than 20 years of experience in radiopharmaceuticals and molecular imaging, we provide solutions for radiolabelling, dosimetry, regulatory issues and the intricacies of functional imaging that are frequently seen as major obstacles in the conduct of oncology and imaging trials.

Hand turning knob to select phases of clinical trial.


Our unique team of scientists and non-clinical as well as clinical research experts is there to support the development of your medicinal product or device from concept to market.

Hand turning knob to select phases of clinical trial.
Image of the human brain with the pathology


Our dedicated Molecular and Functional Imaging Core Lab provides comprehensive turn-key solutions covering all aspects of pre-clinical and clinical Imaging and dosimetry.



ABX-CRO is an independent international CRO providing standard & specialised clinical and non-clinical studies, with emphasis on neuroscience, oncology and diagnostic imaging. With a unique translational medicine approach, we are happy to develop your product from first non-clinical to late-stage multicentre human studies, or to support your marketing authorisation.

Close up of examining of test sample under the microscope in laboratory.

Looking for a job?

Do you want to be part of a team developing cutting-edge therapies and imaging solutions?
Do you want to work in a family-friendly company offering flexible solutions to suit your work-life balance?